| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |